<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Based on the presence of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific over-expression of Plk1 (polo-like kinases) in various <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, we examined Plk1 expression in nine cases of reactive <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> (RFH), 42 of diffuse large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), 16 of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL), and 10 of nasal NK/T <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>There was no significant difference in the Plk1-positive cell percentage between RFH and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The Plk1-positive cell percentage ranged from 6 to 20% with a median of 12.9% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In FL, Plk1-positivity was at most 7% </plain></SENT>
<SENT sid="4" pm="."><plain>Plk1-positivity in nasal NK/T cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (4.7-14.1% with a median of 9.2%) was significantly higher than that of FL and tended to be lower than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (p &lt; 0.001, p = 0.05, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>Although a strong correlation between positive cell percentages for Plk1 and Ki-67 in these three <z:hpo ids='HP_0002665'>lymphomas</z:hpo> specified Plk1 as a proliferation marker (r = 0.83-0.91), the Plk1-positive cell percentage relative to the other proliferation markers tended to be particularly low in nasal NK/T cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In 41 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, the positive cell percentages of Plk1 and Ki-67 were both correlated with overall survival </plain></SENT>
<SENT sid="7" pm="."><plain>The 4-year overall survival rates by Kaplan-Meier analysis for Plk1-negative and positive patients were 80 and 38%, respectively (p = 0.02) </plain></SENT>
</text></document>